Christine D. Copple, Ph.D. is currently President & CEO of Starise Ventures, Inc. Starise provides a team-based approach to entrepreneurs and investors designed to mitigate the intrinsic execution risks of translating biomedical discoveries from the bench to the bedside. Previously she was President & CEO of ASM Resources Inc., the venture arm of the American Society for Microbiology where she built their diversified investment portfolio and created a model for a ‘Single bottom line fund with a double bottom line impact’ for philanthropic venture. Chris joined ASMR after spending six years as Chief Operating Officer at Neuralstem, Inc. developing neural stem cell products for neurodegenerative diseases. Prior to that, as director of the Office of Industry Liaison for the University of Maryland Biotechnology Institute from 1993 to 1996, she was responsible for providing entrepreneurial guidance and services for faculty and start-up companies. For the previous 10 years, Chris was Vice President of Marketing for the public company Microfluidics International.
With more than 25 years of experience in senior management positions at biotechnology growth companies, Dr. Copple is seasoned in public offerings, private/venture investments, joint ventures, licensing and partnering, public corporate reporting, public relations, investor relations, international marketing, product development, regulatory affairs, legislative affairs, and facilities design/buildout. Dr. Copple is a member of the Advisory Board for the Maryland Industrial Partnerships (MIPS) Program and she serves, or has served, as a Board member on a variety of companies and organizations including the Maryland Technology Development Corporation (TEDCO). She received a B.Sc. in Biological Sciences from the University of East Anglia (U.K.) and a Ph.D. in Molecular Biology of Cancer from the University of Birmingham Medical School (U.K.). She came to the U.S. to join the Cell Biology Laboratory at Cold Spring Harbor Laboratory.